Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
123 JPY | -2.38% | 0.00% | -8.89% |
01/04 | Chiome Bioscience Cancels License Agreements with ADC Therapeutics | MT |
13/02 | Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited | CI |
Business Summary
Number of employees: 53
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Discovery Support
100.0
%
| 631 | 100.0 % | 682 | 100.0 % | +8.19% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
96.6
%
| 597 | 94.7 % | 659 | 96.6 % | +10.40% |
Singapore
2.8
%
| 25 | 4.0 % | 19 | 2.8 % | -24.17% |
Europe
0.6
%
| 8 | 1.3 % | 4 | 0.6 % | -52.09% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
President | 70 | 01/09/01 | |
Arihiko Bijohira
BRD | Director/Board Member | 45 | 01/13/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Akiyuki Furuya
BRD | Director/Board Member | 79 | 01/17/01 |
Haruhisa Kubota
BRD | Director/Board Member | 74 | 28/19/28 |
President | 70 | 01/09/01 | |
Arihiko Bijohira
BRD | Director/Board Member | 45 | 01/13/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 55,720,600 | 50,339,051 ( 90.34 %) | 6,149 ( 0.0110 %) | 90.34 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CHIOME BIOSCIENCE INC. 0.00% | 100 | 0.00% | 94 $ |
Company contact information
Chiome Bioscience, Inc.
Sumitomo Fudosan Nishi-Shinjuku Bldg 3-12-1 Hon-machi
151-0071, Tokyo
+
http://www.chiome.co.jpSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-8.89% | 44.82M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- 4583 Stock
- Company Chiome Bioscience Inc.